1Mountain CF. Revisions in the international system for staging lung cancer[J]. Chest, 1997, 111(6):1710～1717
2Pfister DG, Johnson DH, Azzoli GG, et al. American society of clinical oncology treatment of unresectable non-small-cell lung cancer guideline: Update 2003[J].J Clin Oncol, 2004, 22(2):330～353
3Carney DN, Hansen HH. Non-small-cell lung cancer-stalemate or progress [J]? N EnglJ Med, 2000, 343(17):1261～1262
4Jazieh AR, Hussain M, HowingtonJA, et al. Prognostic factors in patients with surgically resected stages Ⅰ and Ⅱ non-small cell lung cancer[J]. Ann Thorac Surg, 2000, 70(4):1168～1171
5Vargas SO, Leslie KO, Vacek PM, et al. Estrogen-receptor-related protein p29 in primary non-small cell lung carcinoma:pathologic and prognostic correlations [J]. Cancer, 1998, 82 (8):1495～1500
6Nesbitt JC, Putnam JB, Walsh GL, et al. Survival in early-stage non-small cell lung cancer [J]. Ann Thorac Surg, 1995, 60(2):466～472
7Fernandes OJ, Almgren SO, Thaning L, et al. Prognostic factors for the survival of surgically treated patients for non-small cell lung cancer [J]. Acta Oncologica, 2003, 42(4):338～341
8Fang D, Zhang D, Huang G, et al. Results of surgical resection of patients with primary lung cancer: a retrospective analysis of 1905 cases[J]. Ann Thorac Surg, 2001, 72(4):1155～1159
9PORT meta-analysis trialists group. Postoperative radiotherapy in non-small-cell lung cancer: systematic review and meta-analysis of individual patient data from nine randomised controlled trials[J]. The Lancet, 1998, 352(9124):257～263
10The International Adjuvant Lung Cancer Trial Collaborative Group. Cisplatin- based adjuvant chemotherapy in patients with completely resected non-small cell lung cancer [J]. N EnglJ Med,2004, 350(4):351～360
